The AIDS 2024 conference occurs on the heels of the PURPOSE 1 PrEP trial announcement. AVAC will be tracking discussion and debate on how to make the full range of PrEP products feasible choices for all people who need and want HIV prevention. We’ll also be following the latest scientific advances, efforts in decolonizing global health, successes in community-led initiatives, and more.
AVAC’s Guide to AIDS 2024 in Munich
Join us as we Commemorate HIV Vaccine Awareness Day
As we prepare to commemorate HIV Vaccine Awareness Day (HVAD) on May 18, the field continues to see some modest scientific breakthroughs, while still facing extraordinary challenges.